Key result
Mianserin preserves cardiac contractility, whereas amitriptyline causes a ~17% decline in healthy volunteers.
Why the study?
The cardiac effects of mianserin compared to amitriptyline, particularly on myocardial contractility, were not well characterized in healthy volunteers.
Does mianserin compared to amitriptyline preserve myocardial contractility in healthy volunteers?
RCT (n=10)
Does mianserin compared to amitriptyline preserve myocardial contractility in healthy volunteers?
Mianserin does not decrease cardiac contractility compared to amitriptyline, suggesting it may be a safer antidepressant choice for patients with cardiac disease.
Answers are grounded in this paper and cite their sources.
May warrant contractility monitoring with amitriptyline; leaves open clinical relevance in cardiac patients.
SummaryTen healthy volunteers were randomly allocated to two groups and treated with increasing doses of mianserin and amitriptyline for 6 days. Heart rate, arterial blood pressure, and blood levels of the drugs were measured daily. ECG and left ventricular echocardiogram, as a parameter of contractility, were registrated before as well as after 3 and 6 days of treatment with both drugs. The most striking result was that amitriptyline-treated subjects showed a loss of myocardial contractility (-17% of the initial value) after 6 days of treatment; mianserin was ineffective in this respect. After both mianserin and amitriptyline, an increase in the mean arterial blood pressure was observed. An increased heart rate was seen only in the amitriptyline group. No alterations in the parameters calculated from the ECG registrations were found in either groups. The inability of mianserin in the therapeutic dose range to decrease cardiac contractility may favour this tetracyclic antidepressant over the tricyclic compound amitriptyline, especially in patients with cardiac disease.
No takes yet. Share an insight, caveat, or question.
Wester et al. (1980) conducted an RCT in Healthy volunteers (n=10). Mianserin vs. Amitriptyline was evaluated on Myocardial contractility. Mianserin did not decrease cardiac contractility after 6 days of treatment, whereas amitriptyline caused a 17% loss of myocardial contractility in healthy volunteers.
Synapse has enriched 10 related papers. Consider them for comparative context: